New technique to identify a cause that is common to diseases related to thrombotic microangiopathies for which there is a treatment

Researchers of the Hospital Clínic-IDIBAPS and the Josep Carreras Leukemia Research Institute have developed a new technique that allows detecting an abnormality in the alternative complement pathway, a fundamental part of the immune system. When this path is deregulated, it can attack the own endothelial cells and cause thrombotic microangiopathy (MAT), a serious and common injury to a number of diseases.